Ajanta Pharma Ltd.
BSE: 532331 | Sector: Health care |
NSE: AJANTPHARM | ISIN Code: INE031B01049 |
BSE 00:00 | 18 May | 1701.05 |
-5.35 (-0.31%) |
OPEN
1705.70 |
HIGH
1719.95 |
LOW
1686.05 |
NSE 00:00 | 18 May | 1702.70 |
-3.85 (-0.23%) |
OPEN
1715.50 |
HIGH
1722.00 |
LOW
1685.00 |
OPEN | 1705.70 |
PREVIOUS CLOSE | 1706.40 |
VOLUME | 1145 |
52-Week high | 2420.00 |
52-Week low | 1593.30 |
P/E | 20.18 |
Mkt Cap.(Rs cr) | 14,527 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Ajanta Pharma Ltd. (AJANTPHARM) - Financial Overview
Particulars (![]() |
2021 | 2020 | 2019 |
Net Sales | 2718.59 | 2196.42 | 1772.62 |
Operating Profit | 1020.48 | 713.06 | 583.36 |
Other Income | 103.57 | 184.20 | 102.15 |
Interest | 6.90 | 9.10 | 0.41 |
Depreciation | 111.49 | 91.29 | 69.90 |
Profit Before Tax | 902.09 | 612.67 | 513.05 |
Tax | 226.45 | 171.54 | 121.29 |
Profit After Tax | 675.64 | 441.13 | 391.76 |
Share Capital | 17.39 | 17.54 | 17.54 |
Reserves | 2867.59 | 2443.76 | 2124.54 |
Net Worth | 2884.98 | 2461.30 | 2142.08 |
Loans | 48.43 | 43.27 | 13.77 |
Gross Block | 2086.54 | 1926.65 | 1555.61 |
Investments | 156.88 | 85.77 | 83.00 |
Cash | 151.98 | 87.85 | 35.87 |
Debtors | 782.30 | 734.24 | 423.38 |
Net Working Capital | 1149.55 | 838.42 | 649.54 |
Operating Profit Margin (%) | 37.54 | 32.46 | 32.91 |
Net Profit Margin (%) | 24.85 | 20.08 | 22.10 |
Earning Per Share (Rs) | 77.70 | 50.30 | 44.67 |
Dividend (%) | 475.00 | 650.00 | 450.00 |
Dividend Payout | 82.90 | 113.44 | 79.22 |
Quick Links for Ajanta Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices